Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer Survivors
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The current archival analyses examine the direct and indirect effects of cognitive behavioral therapy for insomnia (CBT-I) on depression in cancer survivors. We report on 67 cancer survivors from a 2 × 2 randomized controlled trial of CBT-I and armodafinil for insomnia, after collapsing across the noneffective study medication conditions (armodafinil/placebo) to create CBT-I (yes/no). Depression and insomnia were assessed before, during the 7-week CBT-I intervention, at postintervention, and 3 months later by the Patient Health Questionnaire and the Insomnia Severity Index, respectively. Mean depression at baseline for all participants was 6.44 (standard error = 0.41, range 0–15). Paired t tests showed that depression improved from baseline to postintervention by 48% (P < .001) in the CBT-I group versus 15% (P = .016) in the non-CBT-I group. Analysis of covariance controlling for baseline found that participants receiving CBT-I had significantly less depression at postintervention (effect size = −0.62; P = .001), compared to those who did not receive CBT-I. These benefits were maintained at the 3-month follow-up. Spearman rank correlations showed that changes in insomnia severity from baseline to postintervention were significantly correlated with concurrent changes in depression (r = .73; P < .001). Path analysis revealed that improvement in depression was mediated by improvement in insomnia severity (P < .001). Our findings provide preliminary support that in cancer survivors, CBT-I reduces depression via improvement in insomnia. Further, this reduction in depression remained stable 3 months after completing CBT-I. This suggests that a CBT-I intervention has a meaningful effect on depression. Registry: ClinicalTrials.gov; Title: Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy; Identifier: NCT01091974; URL: https://clinicaltrials.gov/ct2/show/record/NCT01091974 Peoples AR, Garland SN, Pigeon WR, Perlis ML, Wolf JR, Heffner KL, Mustian KM, Heckler CE, Peppone LJ, Kamen CS, Morrow GR, Roscoe JA. Cognitive behavioral therapy for insomnia reduces depression in cancer survivors. J Clin Sleep Med 2019;15(1):129–137.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449 · cited 2×
“28 The parent trial was a four-arm factorial study of CBT-I (yes/no) versus armodafinil (yes/no), in which participants were randomized to one of the four intervention arms: (1) CBT-I+placebo; (2) CBT-I+armodafinil; (3) armodafinil; and (4) placebo.”
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Depression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
Krebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., de Bree, R., Leemans, C. R., Becker, A., Brug, J., van Straten, A., Cuijpers, P., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3409 · Cited by 908
Sleep Deprivation and Activation of Morning Levels of Cellular and Genomic Markers of Inflammation
Irwin, M. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.16.1756 · Cited by 850 · cited 1×
“4,10,41 These proinflammatory cytokines can dysregulate cortisol levels, cause HPA axis dysfunc - tion, and cross the blood-brain barrier, resulting in oxida - tive stress and inflammation in the brain.”
Palesh, O. G., Roscoe, J. A., Mustian, K. M., Roth, T., Savard, J., Ancoli-Israel, S., Heckler, C., Purnell, J. Q., Janelsins, M. C., & Morrow, G. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5011 · Cited by 557
Self-citationSavard, M.-H., Savard, J., Simard, S., & Ivers, H. (2005) · Psycho-Oncology · doi:10.1002/pon.860 · Cited by 449
Espie, C. A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L. M., White, C. A., Douglas, N. J., Engleman, H. M., Kelly, H.-L., & Paul, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9006 · Cited by 383 · cited 1×
“These findings are consistent with previous studies that have also shown a secondary benefit of CBT-I on reducing depression in cancer survivors in addition to ameliorating subjective sleep difficul - ties 22–24 and that treatment benefits were sustained over time.”
Johnson, J. A., Rash, J. A., Campbell, T. S., Savard, J., Gehrman, P. R., Perlis, M., Carlson, L. E., & Garland, S. N. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.07.001 · Cited by 371
Self-citationRitterband, L. M., Bailey, E. T., Thorndike, F. P., Lord, H. R., Farrell‐Carnahan, L., & Baum, L. D. (2012) · Psycho-Oncology · doi:10.1002/pon.1969 · Cited by 296
Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
Hinz, A., Mehnert, A., Kocalevent, R.-D., Brähler, E., Forkmann, T., Singer, S., & Schulte, T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0728-6 · Cited by 272
Effect of insomnia treatments on depression: A systematic review and meta-analysis
Gebara, M. A., Siripong, N., DiNapoli, E. A., Maree, R. D., Germain, A., Reynolds, C. F., Kasckow, J. W., Weiss, P. M., & Karp, J. F. (2018) · Depression and Anxiety · doi:10.1002/da.22776 · Cited by 247
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236 · cited 2×
“28 The parent trial was a four-arm factorial study of CBT-I (yes/no) versus armodafinil (yes/no), in which participants were randomized to one of the four intervention arms: (1) CBT-I+placebo; (2) CBT-I+armodafinil; (3) armodafinil; and (4) placebo.”
Pigeon, W. R., Bishop, T. M., & Krueger, K. M. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0802-x · Cited by 233
Self-citationIrwin, M. R., Olmstead, R., Breen, E. C., Witarama, T., Carrillo, C., Sadeghi, N., Arevalo, J. M. G., Ma, J., Nicassio, P., Bootzin, R., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.010 · Cited by 227
Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors
Dirksen, S. R., & Epstein, D. R. (2008) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2007.04560.x · Cited by 185 · cited 1×
“This finding is consistent with a study in breast cancer survivors by Dirksen and Epstein, 37 which found through me - diational analysis that CBT-I did not have a direct effect on psychosocial outcomes, such as depression, although they did not assess the indirect effect of the intervention.”
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Savard, J., Ivers, H., Savard, M.-H., & Morin, C. M. (2014) · Sleep · doi:10.5665/sleep.3918 · Cited by 136 · cited 1×
“These findings are consistent with previous studies that have also shown a secondary benefit of CBT-I on reducing depression in cancer survivors in addition to ameliorating subjective sleep difficul - ties 22–24 and that treatment benefits were sustained over time.”
Ashworth, D. K., Sletten, T. L., Junge, M., Simpson, K., Clarke, D., Cunnington, D., & Rajaratnam, S. M. W. (2015) · Journal of Counseling Psychology · doi:10.1037/cou0000059 · Cited by 131 · cited 1×
“…comorbid in - somnia and depression did find that improvement in insomnia mediated the improvement in depression with no direct effects of CBT-I on depression, 27 no study to date in cancer survivors has evaluated whether the effects of CBT-I on depression are mediated by improvements in insomnia.”
Matthews, E. E., Berger, A. M., Schmiege, S. J., Cook, P. F., McCarthy, M. S., Moore, C. M., & Aloia, M. S. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.41-03ap · Cited by 103 · cited 1×
“21 26 Additionally, though one study in the general population with comorbid in - somnia and depression did find that improvement in insomnia mediated the improvement in depression with no direct effects of CBT-I on depression, 27 no study to date in cancer survivors has evaluated whether the…”
Exercise interventions to improve sleep in cancer patients: a systematic review and meta-analysis
Mercier, J., Savard, J., & Bernard, P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.11.001 · Cited by 103
Cited by
Scott, A. J., Webb, T. L., Martyn-St James, M., Rowse, G., & Weich, S. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101556 · Cited by 1,094
Squires, L. R., Rash, J. A., Fawcett, J., & Garland, S. N. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101615 · Cited by 85
Self-citationLiving with persistent insomnia after cancer: A qualitative analysis of impact and management
Reynolds‐Cowie, P., & Fleming, L. (2021) · British Journal of Health Psychology · doi:10.1111/bjhp.12446 · Cited by 53
Amidi, A., Buskbjerg, C. R., Damholdt, M. F., Dahlgaard, J., Thorndike, F. P., Ritterband, L., & Zachariae, R. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.04.020 · Cited by 41
Garland, S. N., Tulk, J., Savard, J., Rash, J. A., Browne, S., Urquhart, R., Seal, M., Thoms, J., & Laing, K. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02330 · Cited by 29
Self-citation
Metadata
- Authors
- Peoples, A. R., Garland, S. N., Pigeon, W. R., Perlis, M. L., Wolf, J. R., Heffner, K. L., Mustian, K. M., Heckler, C. E., Peppone, L. J., Kamen, C. S., Morrow, G. R., & Roscoe, J. A.
- Venue
- Journal of Clinical Sleep Medicine
- Published
- 2019-01-15
- Volume
- 15
- Issue
- 1
- Pages
- 129-137
- ISSN
- 1550-9389 (ISSN-L)
- 1550-9397
- OpenAlex
- W2909632784
- Cited by
- 72
- References
- 24
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.